Quantcast

Latest Antidepressants Stories

3e6cab76c277c5016f8def24547b3b7b1
2010-06-19 07:10:00

On Friday, a U.S. panel of experts debated to approve the first pill that helps boost a woman's sex drive, as its German manufacturer pressed for the drug to reach the lucrative market. Boehringer Ingelheim officials wanted to convince the U.S. Food and Drug Administration (FDA) that their little pink pill was harmless and effective. The FDA usually follows these panels' advice, even though it is not required to do so by law. Flibanserin is the latest effort to come up with a female...

2010-06-18 15:32:00

RIDGEFIELD, Conn., June 18 /PRNewswire/ -- The Reproductive Health Drugs Advisory Committee met today to discuss the new drug application (NDA) for flibanserin 100 mg as a treatment for Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women. The advisory committee was convened by and makes recommendations to the U.S. Food and Drug Administration (FDA). The FDA will consider the committee's advice as part of its final assessment of the NDA. The committee recognized the...

fb905fc98aa63cd7e7d7349aa679b00b1
2010-06-17 06:35:00

The drug industry's latest attempt to find a female equivalent to Viagra fell short in two separate studies, according to federal regulators on Wednesday. The Food and Drug Administration is considering Boehringer Ingelheim's drug flibanserin for pre-menopausal women who experienced a lack in sexual desire, a market that drug makers have been targeting for years since the epic success of Viagra for men. The hunt for a female version of Viagra has proved elusive though, with many drugs...

2010-05-24 13:49:10

Exposure to specific bacteria in the environment, already believed to have antidepressant qualities, could increase learning behavior according to research presented today at the 110th General Meeting of the American Society for Microbiology in San Diego. "Mycobacterium vaccae is a natural soil bacterium which people likely ingest or breath in when they spend time in nature," says Dorothy Matthews of The Sage Colleges in Troy, New York, who conducted the research with her colleague Susan...

2010-05-19 11:30:46

New analyses from pivotal Phase III flibanserin trials presented May 18 Data from pivotal Phase III clinical trials demonstrate that a higher proportion of pre-menopausal women with Hypoactive Sexual Desire Disorder (HSDD) receiving flibanserin 100mg reported both an improvement in their condition and a meaningful benefit from their treatment, compared to placebo. Flibanserin is an investigational compound being developed by Boehringer Ingelheim Pharmaceuticals, Inc. for the treatment of HSDD...

2010-05-18 17:30:00

RIDGEFIELD, Conn., May 18 /PRNewswire/ -- Data from pivotal Phase III clinical trials demonstrate that a higher proportion of pre-menopausal women with Hypoactive Sexual Desire Disorder (HSDD) receiving flibanserin 100mg reported both an improvement in their condition and a meaningful benefit from their treatment, compared to placebo. Flibanserin is an investigational compound being developed by Boehringer Ingelheim Pharmaceuticals, Inc. for the treatment of HSDD in pre-menopausal women....

2010-05-05 06:00:00

LAVAL, QC and PRINCETON, NJ, May 5 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the appointment of Jeffrey M. Dayno, M.D. as Chief Medical Officer. Dr. Dayno will be responsible for leading the clinical activities for Labopharm's drug development programs, as well as overseeing the Company's medical affairs functions, including medical information and pharmacovigilance, for all commercialized products. Dr. Dayno will be based out of Labopharm's U.S. office...

2010-04-29 06:02:00

- U.S. Launch of OLEPTRO(TM) on Track for Third Quarter 2010 - PRINCETON, NJ, LAVAL, QC and ROME, Italy, April 29 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) and Gruppo Angelini today announced they have entered into an agreement to establish a joint venture in the United States for the commercialization of OLEPTRO(TM), a novel once-daily formulation of the antidepressant trazodone approved by the U.S. Food and Drug Administration on February 3, 2010. "This joint venture...

2010-02-25 21:50:00

LOS ANGELES, Feb. 25 /PRNewswire/ -- Through her site www.OrganicLiaison.com, award-winning actress Kirstie Alley has launched a brand new, innovative, affordable weight-loss program featuring the 'Rescue Me' kit. Developed with top doctors and nutritionists from around the country, the program consists of the 'Rescue Me' Elixir, which provides the body with the nutrients, minerals, pre-biotics, and anti-oxidants it needs to curb excess-hunger and cravings. 'Release Me,' an advanced...

2010-02-03 06:00:00

LAVAL, QC and PRINCETON, NJ, Feb. 3 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances...


Latest Antidepressants Reference Libraries

2012-06-15 03:50:16

Symbol: MUPRU Group: Dicot Family: Fabaceae Duration: Annual Growth Habit: Vine Forb/herb Native Status: L48    N Synonyms:   MUAT2 Mucuna aterrima (Piper & Tracy) Holland   MUDE2 Mucuna deeringiana (Bort) Merr.   STAT3 Stizolobium aterrimum Piper & Tracy   STDE Stizolobium deeringianum Bort   STVE5 Stizolobium velutinum (Hassk.) Piper & Tracy Distribution: Mucunapruriens(L.) DC. var.utilis(Wall. ex Wight) Baker ex Burck...

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related